Sfoglia per Autore
Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD.
1992-01-01 Merola, B; Rossi, E; Longobardi, S; Selleri, A; Esposito, V; Colao, A; Cataldi, M; Ferone, Diego; Lombardi, G.
Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly.
1993-01-01 Merola, B; Cittadini, A; Colao, A; Ferone, Diego; Fazio, S; Sabatini, D; Biondi, B; Saccà, L; Lombardi, G.
Hypothalamic-pituitary-adrenal axis in neuropsychiatric disorders.
1994-01-01 Merola, B; Longobardi, S; Colao, A; Di Somma, C; Ferone, Diego; Rossi, E; Covelli, V; Lombardi, G.
Positive response to compound CV 205-502 in hyperprolactinemic patients resistant or intolerant of bromocriptine.
1994-01-01 Merola, B; Sarnacchiaro, F; Colao, A; Di Somma, C; Di Sarno, A; Ferone, Diego; Selleri, A; Landi, Ml; Schettini, G; Nappi, C; Lombardi, G.
Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.
1994-01-01 Colao, A; Merola, B; Ferone, Diego; Calabrese, Mr; Longobardi, S; Spaziante, Renato; Di Renzo, G; Annunziato, L; Lombardi, G.
CV 205-502 treatment in therapy-resistant acromegalic patients.
1995-01-01 Lombardi, G; Colao, A; Ferone, Diego; Sarnacchiaro, F; Marzullo, P; Di Sarno, A; Rossi, E; Merola, B.
Impaired luteinizing hormone responsiveness to gonadotropin-releasing hormone in the inferior petrosal sinuses of hyperprolactinemic patients.
1995-01-01 Colao, A; Merola, B; Di Sarno, A; La Tessa, G; Ferone, Diego; Cerbone, G; Marzullo, P; Lombardi, G.
Comparison among different dopamine-agonists of new formulation in clinical management of macroprolactinomas.
1995-01-01 Colao, A; Merola, B; Sarnacchiaro, F; Di Sarno, A; Landi, Ml; Marzullo, P; Cerbone, G; Ferone, Diego; Lombardi, G.
Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas.
1995-01-01 Lastoria, S; Colao, A; Vergara, E; Ferone, Diego; Varrella, P; Merola, B; Lombardi, G; Salvatore, M.
Acute and chronic effects of octreotide on thyroid axis in GH-secreting and clinically nonfuctioning pituitary adenomas.
1995-01-01 Colao, A; Merola, B; Ferone, Diego; Marzullo, P; Cerbone, G; Longobardi, S; Di Somma, C; Lombardi, G.
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing’s disease.
1996-01-01 Colao, A; Merola, B; Di Sarno, A; Ferone, Diego; Marzullo, P; La Tessa, G; Boudouresque, F; Oliver, C; Lombardi, G.
Cardiovascular aspects in acromegaly: effects of treatment.
1996-01-01 Lombardi, G; Colao, A; Ferone, Diego; Marzullo, P; Landi, Ml; Longobardi, S; Iervolino, E; Cuocolo, A; Fazio, S; Merola, B.
Tumor necrosis factor-alpha increases after corticotropin-releasing hormone stimulation in Cushing’s disease: in vivo and in vitro studies.
1996-01-01 Merola, B; Longobardi, S; Colao, A; Di Somma, C; Ferone, Diego; Di Rella, F; Pivonello, R; Covelli, V; Lombardi, G.
Prediction of efficacy of octreotide therapy in patients with acromegaly.
1996-01-01 Colao, A; Ferone, Diego; Lastoria, S; Marzullo, P; Cerbone, G; Di Sarno, A; Longobardi, S; Merola, B; Salvatore, M; Lombardi, G.
Vasopressin levels in Cushing’s disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing’s disease.
1996-01-01 Colao, A; Ferone, Diego; Di Sarno, A; Tripodi, Fs; Cerbone, G; Marzullo, P; Boudouresque, F; Oliver, C; Merola, B; Lombardi, G.
Increased prevalence of colonic polyps and altered lymphocyte subsets in the colonic lamina propria in acromegaly.
1997-01-01 Colao, A; Balzano, A; Ferone, Diego; Panza, N; Grande, G; Marzullo, P; Bove, A; Iodice, G; Merola, B; Lombardi, G.
Failure of long-term therapy with sodium valproate in Cushing’s disease.
1997-01-01 Colao, A; Pivonello, R; Tripodi, Fs; Orio F., Jr; Ferone, Diego; Cerbone, G; Di Somma, C; Merola, B; Lombardi, G.
Acute administration of hexarelin stimulates GH secretion during day and night in normal men.
1997-01-01 Loche, S; Colao, A; Cappa, M; Ferone, Diego; Merola, B; Faedda, A; Imbimbo, Bp; Deghenghi, R; Lombardi, G.
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment
1997-01-01 Colao, A.; Di Sarno, A.; Sarnacchiaro, F.; Ferone, D.; Di Renzo, G.; Merola, B.; Annunziato, L.; Lombardi, G.
Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
1997-01-01 Lombardi, G; Colao, A; Marzullo, P; Ferone, Diego; Longobardi, S; Esposito, V; Merola, B.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD. | 1-gen-1992 | Merola, B; Rossi, E; Longobardi, S; Selleri, A; Esposito, V; Colao, A; Cataldi, M; Ferone, Diego; Lombardi, G. | |
Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly. | 1-gen-1993 | Merola, B; Cittadini, A; Colao, A; Ferone, Diego; Fazio, S; Sabatini, D; Biondi, B; Saccà, L; Lombardi, G. | |
Hypothalamic-pituitary-adrenal axis in neuropsychiatric disorders. | 1-gen-1994 | Merola, B; Longobardi, S; Colao, A; Di Somma, C; Ferone, Diego; Rossi, E; Covelli, V; Lombardi, G. | |
Positive response to compound CV 205-502 in hyperprolactinemic patients resistant or intolerant of bromocriptine. | 1-gen-1994 | Merola, B; Sarnacchiaro, F; Colao, A; Di Somma, C; Di Sarno, A; Ferone, Diego; Selleri, A; Landi, Ml; Schettini, G; Nappi, C; Lombardi, G. | |
Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies. | 1-gen-1994 | Colao, A; Merola, B; Ferone, Diego; Calabrese, Mr; Longobardi, S; Spaziante, Renato; Di Renzo, G; Annunziato, L; Lombardi, G. | |
CV 205-502 treatment in therapy-resistant acromegalic patients. | 1-gen-1995 | Lombardi, G; Colao, A; Ferone, Diego; Sarnacchiaro, F; Marzullo, P; Di Sarno, A; Rossi, E; Merola, B. | |
Impaired luteinizing hormone responsiveness to gonadotropin-releasing hormone in the inferior petrosal sinuses of hyperprolactinemic patients. | 1-gen-1995 | Colao, A; Merola, B; Di Sarno, A; La Tessa, G; Ferone, Diego; Cerbone, G; Marzullo, P; Lombardi, G. | |
Comparison among different dopamine-agonists of new formulation in clinical management of macroprolactinomas. | 1-gen-1995 | Colao, A; Merola, B; Sarnacchiaro, F; Di Sarno, A; Landi, Ml; Marzullo, P; Cerbone, G; Ferone, Diego; Lombardi, G. | |
Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas. | 1-gen-1995 | Lastoria, S; Colao, A; Vergara, E; Ferone, Diego; Varrella, P; Merola, B; Lombardi, G; Salvatore, M. | |
Acute and chronic effects of octreotide on thyroid axis in GH-secreting and clinically nonfuctioning pituitary adenomas. | 1-gen-1995 | Colao, A; Merola, B; Ferone, Diego; Marzullo, P; Cerbone, G; Longobardi, S; Di Somma, C; Lombardi, G. | |
Corticotropin-releasing hormone administration increases alpha-melanocyte-stimulating hormone levels in the inferior petrosal sinuses in a subset of patients with Cushing’s disease. | 1-gen-1996 | Colao, A; Merola, B; Di Sarno, A; Ferone, Diego; Marzullo, P; La Tessa, G; Boudouresque, F; Oliver, C; Lombardi, G. | |
Cardiovascular aspects in acromegaly: effects of treatment. | 1-gen-1996 | Lombardi, G; Colao, A; Ferone, Diego; Marzullo, P; Landi, Ml; Longobardi, S; Iervolino, E; Cuocolo, A; Fazio, S; Merola, B. | |
Tumor necrosis factor-alpha increases after corticotropin-releasing hormone stimulation in Cushing’s disease: in vivo and in vitro studies. | 1-gen-1996 | Merola, B; Longobardi, S; Colao, A; Di Somma, C; Ferone, Diego; Di Rella, F; Pivonello, R; Covelli, V; Lombardi, G. | |
Prediction of efficacy of octreotide therapy in patients with acromegaly. | 1-gen-1996 | Colao, A; Ferone, Diego; Lastoria, S; Marzullo, P; Cerbone, G; Di Sarno, A; Longobardi, S; Merola, B; Salvatore, M; Lombardi, G. | |
Vasopressin levels in Cushing’s disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing’s disease. | 1-gen-1996 | Colao, A; Ferone, Diego; Di Sarno, A; Tripodi, Fs; Cerbone, G; Marzullo, P; Boudouresque, F; Oliver, C; Merola, B; Lombardi, G. | |
Increased prevalence of colonic polyps and altered lymphocyte subsets in the colonic lamina propria in acromegaly. | 1-gen-1997 | Colao, A; Balzano, A; Ferone, Diego; Panza, N; Grande, G; Marzullo, P; Bove, A; Iodice, G; Merola, B; Lombardi, G. | |
Failure of long-term therapy with sodium valproate in Cushing’s disease. | 1-gen-1997 | Colao, A; Pivonello, R; Tripodi, Fs; Orio F., Jr; Ferone, Diego; Cerbone, G; Di Somma, C; Merola, B; Lombardi, G. | |
Acute administration of hexarelin stimulates GH secretion during day and night in normal men. | 1-gen-1997 | Loche, S; Colao, A; Cappa, M; Ferone, Diego; Merola, B; Faedda, A; Imbimbo, Bp; Deghenghi, R; Lombardi, G. | |
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment | 1-gen-1997 | Colao, A.; Di Sarno, A.; Sarnacchiaro, F.; Ferone, D.; Di Renzo, G.; Merola, B.; Annunziato, L.; Lombardi, G. | |
Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly. | 1-gen-1997 | Lombardi, G; Colao, A; Marzullo, P; Ferone, Diego; Longobardi, S; Esposito, V; Merola, B. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile